Sign In
Buy ALRN
$2.11
+0 (+0%)
At Close: Apr 09, 2025
How to Trade Penny Stocks in August 2022
03:30pm, Sunday, 07'th Aug 2022 PennyStocks
What you need to know about trading penny stocks in August
The post How to Trade Penny Stocks in August 2022 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
How to Trade Penny Stocks in August 2022
11:30am, Sunday, 07'th Aug 2022
What you need to know about trading penny stocks in August The post How to Trade Penny Stocks in August 2022 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Why Is Marker Therapeutics Trading Higher By 119%: Here Are 42 Stocks Moving Premarket
11:35am, Friday, 05'th Aug 2022 Benzinga
Gainers
Assure Holdings Corp. (NASDAQ: IONM) shares rose 141.4% to $5.07 in pre-market trading after jumping around 104% on Thursday.
Marker Therapeutics, Inc. (NASDAQ: MRKR) shares rose 119% to $0.7
Why Shares Of Cannabis Companies Traded Higher; Here Are 101 Biggest Movers From Yesterday
10:07am, Wednesday, 03'rd Aug 2022 Benzinga
Gainers
MMTec, Inc. (NASDAQ: MTC) shares gained 390.6% to close at $7.85 on Tuesday amid volatility in nano-cap Chinese stocks.
Applied DNA Sciences, Inc. (NASDAQ: APDN) surged 296.9% to settle at $2
Why Applied DNA Sciences Is Trading Higher By 166%, Here Are 75 Stocks Moving In Tuesday's Mid-Day Session
04:41pm, Tuesday, 02'nd Aug 2022 Benzinga
Gainers
AMTD IDEA Group (NYSE: AMTD) shares jumped 284% to $8.00 after jumping 18% on Monday. The company owns 90%+ of AMTD Digital.
Applied DNA Sciences, Inc. (NASDAQ: APDN) gained 166% to $1.8801
Why Revlon Shares Jumped 90%; Here Are 83 Biggest Movers From Yesterday
09:01am, Tuesday, 02'nd Aug 2022 Benzinga
Gainers
Liberty TripAdvisor Holdings, Inc. (NASDAQ: LTRPB) shares jumped 187.3% to close at $48.03 on Monday after gaining around 18% on Friday.
Virax Biolabs Group Limited (NASDAQ: VRAX) climbed 11
Aileron Therapeutics Is Pleased to Outline Strategy to Strengthen Phase 1b Clinical Trial of ALRN-6924 in Patients with p53-Mutated Breast Cancer
11:51am, Monday, 01'st Aug 2022 GlobeNewswire Inc.
BOSTON, Aug. 01, 2022 (GLOBE NEWSWIRE) -- Aileron Therapeutics (Nasdaq: ALRN), a chemoprotection oncology company that aspires to make chemotherapy safer and thereby more effective to save more pati
Citigroup, Bank of America And 48 Stocks Moving In Friday's Mid-Day Session
04:11pm, Friday, 15'th Jul 2022 Benzinga
Gainers
United Maritime Corporation (NASDAQ: USEA) shares jumped 180.9% to $6.19. United Maritime, on Tuesday, announced acquisition of four oil tankers and filed for stock offering on Wednesday.
Ce
Aileron Therapeutics to Participate in Fireside Chat at the William Blair Biotech Focus Conference 2022
12:31pm, Friday, 08'th Jul 2022 GlobeNewswire Inc.
BOSTON, July 08, 2022 (GLOBE NEWSWIRE) -- Aileron Therapeutics (Nasdaq: ALRN), a chemoprotection oncology company that aspires to make chemotherapy safer and thereby more effective to save more pati
Akerna Shares Dip 53%, Here's 78 Biggest Movers From Yesterday
08:52am, Friday, 01'st Jul 2022 Benzinga
Gainers
Revelation Biosciences, Inc. (NASDAQ: REVB) surged 77.4% to close at $1.11 on Thursday after jumping 27% on Wednesday. Revelation Biosciences recently announced completion of dosing for Phas
This Healthcare Stock Surges Around 115%, Here's 74 Biggest Movers From Yesterday
08:55am, Thursday, 30'th Jun 2022 Benzinga
Gainers
Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) shares surged 114.3% to close at $0.2550 on Wednesday after the company announced it has terminated its previously announced at-the-market offerin
Why Is Allena Pharmaceuticals Jumping By 207%? 45 Stocks Moving In Wednesday's Mid-Day Session
04:32pm, Wednesday, 29'th Jun 2022 Benzinga
Gainers
Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) jumped 207% to $0.3650 after the company announced it has terminated its previously announced at-the-market offering.
Brickell Biotech, Inc. (NASD
BOSTON, June 29, 2022 (GLOBE NEWSWIRE) -- Aileron Therapeutics (Nasdaq: ALRN), a chemoprotection oncology company that aspires to make chemotherapy safer and thereby more effective to save more pati
Aileron Therapeutics Announces First Patients Treated in Phase 1b Trial of ALRN-6924 in Patients with p53-Mutated Neoadjuvant Breast Cancer
11:00am, Thursday, 19'th May 2022 GlobeNewswire Inc.
BOSTON, May 19, 2022 (GLOBE NEWSWIRE) -- Aileron Therapeutics (Nasdaq: ALRN), a chemoprotection oncology company that aspires to make chemotherapy safer and thereby more effective to save more patie
3 Oversold Biotech Stocks to Buy Now
06:40am, Thursday, 19'th May 2022
Looking for oversold biotech stocks? These three have all seen significant drops this year despite promising catalysts for the future.
